CEL-SCI Corporation CVM

KEEP BUY to 1400$

Merck is the likely buyer of CVM.

Remember haters, the same FDA that approved COVID vaccines for children and fertile women has denied Multikine. This is about corruption and money, not health and science. Zero toxicity with even marginal results should have been approved in this population where endpoint is death. Faith in the product is justified. Faith in the process is not.

Big picture here. This is a CANCER drug. The untreated outcome is DEATH. The FDA should not review this the same way they review a drug for HBP. MK has ZERO toxicity and the PIII trial did show promise. In this scenario, why not give some type of conditional approval and let the oncologists decide if it has merit? What happened to Biden’s “cancer moonshot”? This is the same FDA that has approved a COVID vaccine for age groups where the risks actually any potential benefit (children/young women). This is the heavy hand of corruption from BP. There is a new sheriff in town and Geert should have already called RFK,Jr.

This was always the plan. Beat CVM into submission so their zero toxicity cancer drug could be acquired cheaply by a Big Pharma player to boost their portfolio. Watch how amazingly quick approval for MK comes after acquisition.

The Keytruda indication is exactly why MK has been basically ignored by the FDA. They have been bought off to look the other way. The fact Keytruda failed its initial application is another indictment against the FDA bc MK has ZERO TOXICITY! Yes, Geert is clearly inept or corrupt. But the 40% increase in 5 yr survival rate with MK should have been enough for some type of approval. I’m not sure that there are any anti-cancer drugs with ZERO toxicity.

As I have posted, any reasonable survival data in a CANCER study - where the untreated outcome is DEATH - where the drug under investigation has ZERO TOXICITY- should get some level of fast track approval. What we are dealing with here is corruption. Any decent CEO would have gotten some type of approval unless they were in bed with a big pharma company involved in the FDA slow walk. Watch for Merck buying out CVM on the cheap as Keytruda will be facing patent expiration

Do not lose sight of the fact this company does have intellectual property with value. I think Geert is most likely corrupt than inept. We know the FDA is corrupt. In the end a big pharmaceutical player will sweep in and buy this company for $20/s. Within 6 mos of that sale MK will magically be approved.

Firing Geert will bring attention to MK and the trial results. This will cause a nice initial pop followed by a huge short squeeze.

Eli Lily gets a drug approved for Alzheimer’s that I guarantee you does not have the demonstrated efficacy of Multikine. Yet here we are. Stuck with Geert and a $1 stock